Since the early 1990s, when Roberts and Szabos cytoprotection concept had already been more than one decade old, but still not implemented in therapy, we suggest the stable gastric pentadecapeptide BPC 157 as the most relevant mediator of the cytoprotection concept.
10.1016/j.lfs.2024.122671 76 ElnosaryM
In addition to genetics, other hyperuricaemia/gout risk factors include: 1, 5, 6 Older age Male sex Obesity Cardio-metabolic co-morbidities, particularly CKD, hypertension and hyperlipidaemia Use of medicines that influence urate production, reabsorption or excretion, e.g
Any change should be agreed with the clinician or GP managing your care
Journal of Peptide Science , 2000 Investigated AOD9604's fat-reducing properties and metabolic effects in obese animal models